Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Epilepsy, Partial
Interventions
DRUG

lamotrigine, 300 mg/day

300 mg/day

DRUG

lamotrigine, 250 mg/day

250 mg/day

Trial Locations (103)

1181

GSK Investigational Site, Capital Federal

1425

GSK Investigational Site, Buenos Aires

11559

GSK Investigational Site, Lawrence

11803

GSK Investigational Site, Plainview

13210

GSK Investigational Site, Syracuse

18960

GSK Investigational Site, Sellersville

19107

GSK Investigational Site, Philadelphia

19713

GSK Investigational Site, Newark

20817

GSK Investigational Site, Bethesda

21005

GSK Investigational Site, Vinnitsa

21061

GSK Investigational Site, Glen Burnie

21208

GSK Investigational Site, Pikesville

25301

GSK Investigational Site, Charleston

26506

GSK Investigational Site, Morgantown

28803

GSK Investigational Site, Asheville

30033

GSK Investigational Site, Decatur

30338

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

32224

GSK Investigational Site, Jacksonville

33351

GSK Investigational Site, Sunrise

33470

GSK Investigational Site, Loxahatchee Groves

33613

GSK Investigational Site, Tampa

35007

GSK Investigational Site, Alabaster

39401

GSK Investigational Site, Hattiesburg

40202

GSK Investigational Site, Louisville

40513

GSK Investigational Site, Lexington

40536

GSK Investigational Site, Lexington

48202

GSK Investigational Site, Detroit

49005

GSK Investigational Site, Dnipro

50309

GSK Investigational Site, Des Moines

53215

GSK Investigational Site, Milwaukee

53715

GSK Investigational Site, Madison

55455

GSK Investigational Site, Minneapolis

56303

GSK Investigational Site, Saint Cloud

60422

GSK Investigational Site, Flossmoor

60611

GSK Investigational Site, Chicago

60637

GSK Investigational Site, Chicago

61068

GSK Investigational Site, Kharkiv

61801

GSK Investigational Site, Urbana

63104

GSK Investigational Site, St Louis

63110

GSK Investigational Site, St Louis

64111

GSK Investigational Site, Kansas City

65006

GSK Investigational Site, Odesa

69057

GSK Investigational Site, Zaporizhzhya

70115

GSK Investigational Site, New Orleans

72703

GSK Investigational Site, Fayetteville

73112

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

76502

GSK Investigational Site, Temple

77025

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

78258

GSK Investigational Site, San Antonio

79021

GSK Investigational Site, Lviv

81902

GSK Investigational Site, Las Vegas

83037

GSK Investigational Site, Donetsk

83702

GSK Investigational Site, Boise

84047

GSK Investigational Site, Midvale

85003

GSK Investigational Site, Phoenix

85013

GSK Investigational Site, Phoenix

85201

GSK Investigational Site, Mesa

85340

GSK Investigational Site, Litchfield Park

85724

GSK Investigational Site, Tucson

85741

GSK Investigational Site, Tucson

89014

GSK Investigational Site, Henderson

89106

GSK Investigational Site, Las Vegas

90073

GSK Investigational Site, Los Angeles

90404

GSK Investigational Site, Santa Monica

91045

GSK Investigational Site, Luhansk

91105

GSK Investigational Site, Pasadena

92705

GSK Investigational Site, Santa Ana

98055

GSK Investigational Site, Renton

105066

GSK Investigational Site, Moscow

117049

GSK Investigational Site, Moscow

125412

GSK Investigational Site, Moscow

193019

GSK Investigational Site, Saint Petersburg

193167

GSK Investigational Site, Saint Petersburg

194291

GSK Investigational Site, Saint Petersburg

443095

GSK Investigational Site, Samara

620102

GSK Investigational Site, Yekaterinburg

7500710

GSK Investigational Site, Providencia / Santiago

7560356

GSK Investigational Site, Santiago

06810

GSK Investigational Site, Danbury

06824

GSK Investigational Site, Fairfield

01104

GSK Investigational Site, Springfield

08818

GSK Investigational Site, Edison

08043

GSK Investigational Site, Vorhees

43210-1296

GSK Investigational Site, Columbus

Unknown

GSK Investigational Site, Capital Fefderal

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Santiago

GSK Investigational Site, San José

GSK Investigational Site, Kyiv

GSK Investigational Site, Poltava

00918

GSK Investigational Site, San Juan

00936

GSK Investigational Site, San Juan

614-735

GSK Investigational Site, Busan

700-712

GSK Investigational Site, Daegu

301-721

GSK Investigational Site, Daejeon

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

135-170

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

02660

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY